Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/04/2005US20050170440 Treatment and diagnosis of insulin-resistant states
08/04/2005US20050170427 For activated slides for preparing microarrays of nucleic acids; solid phase synthesis
08/04/2005US20050170425 Hybridizing microorganism cDNA with probes linked to magnetic bead within tube, transferring to magnetic wells for washing, adding blocking solution, adding avidin enzyme complex or streptavidin enzyme complex, rewashing, suspending magnetic beads, and detecting luminescence or color change; kits
08/04/2005US20050170424 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents
08/04/2005US20050170423 Systems and methods for transgenic and targeted mutagenesis screening
08/04/2005US20050170422 Using denaturation and primer specific amplification to ehance concentration of prferential biopolymer sequences; genomic analysis
08/04/2005US20050170420 Bacterial shuttle vectro for transfer of heterologous nucleotide sequences into cells; improving exogenous gene expression
08/04/2005US20050170417 A mutated G-CSF protein having a deletion of an amino acid sequence corresponding to an exon 3 region for use as a diagnostic cancer marker.
08/04/2005US20050170416 Accurate, economical and simple diagnosis of a variety of cancers based on the finding that exon 3 skipping occurs during transcription of the G-CSF gene in cancer patients
08/04/2005US20050170415 Serine protease BSSP6
08/04/2005US20050170412 Microarray for detection of sequence anomalies in preferential genes; genomics
08/04/2005US20050170411 Genes and proteins involved in the biosynthesis of enediyne ring structures
08/04/2005US20050170408 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/04/2005US20050170407 Reagents and methods useful for detecting diseases of the lung
08/04/2005US20050170406 Using Burkitt's lymphoma-172 nucleotide sequences as diagnostic, prognostic and imaging tool in detection and treatment of infection and cell proliferative disorders of urogenital system
08/04/2005US20050170403 Transgenic tumor cell coding matrix protein and heterologous enxzymatic polypetide for use as tool in drug screening and testing
08/04/2005US20050170398 Producing three or more non-identical antibodies in a single recombinant host cell in which a nucleic acid sequence encoding a light chain and nucleic acid sequences encoding different heavy chains are expressed
08/04/2005US20050170397 Novel receptors
08/04/2005US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay
08/04/2005US20050170395 Novel human proteases and polynucleotides encoding the same
08/04/2005US20050170389 Nucleotide sequences coding ligand polypeptides for use in identifying modulators for diagnosis, prevention and treatnment of diabetes, heart and cancer disorders
08/04/2005US20050170386 Method of classifying gene expression strength in lung cancer tissues
08/04/2005US20050170384 Expression vector comprising nucleotide sequences coding protein with sequence similarities to chordin proteins for use as tool in identifying modulator for treatment and prevention of infection and metabolic disorders
08/04/2005US20050170381 Using lymphocytes expressing jun kinase as tools in detecting modulators for treatment of cell proliferative disorders
08/04/2005US20050170376 Combinatorial chemistry
08/04/2005US20050170371 Alopecia, acne, polycystic ovary disease, prostitic hypertrophy, and prostate cancer
08/04/2005US20050170370 Microarray comprising immobilized primers for monitoring RNA expression; transcrptional analysis
08/04/2005US20050170369 Methods for diagnosing a genetic risk for bone loss
08/04/2005US20050170366 Novel hair keratin-associated proteins
08/04/2005US20050170365 Nucleotide sequences coding modified deoxyribonuclease for treatment of pulmonary, autoimmune and/or cystic fibrosis
08/04/2005US20050170364 Novel human kinase protein and polynucleotides encoding the same
08/04/2005US20050170359 Treatment of vascular dysfunction and alzheimer's disease
08/04/2005US20050170358 Using internal transcribed spacer sequences to classify/distinguish between microorganismal strains
08/04/2005US20050170355 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases
08/04/2005US20050170350 Expression cloning methods in filamentous fungi
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050170347 Potentiometric dna microarray, process for producing the same and method of analyzing nucleic acid
08/04/2005US20050170344 Chds as modifiers of the p53 pathway and methods of use
08/04/2005US20050170343 Modulating insulin receptor signaling
08/04/2005US20050170337 Nucleotide sequences coding coiled-coil viral oligomer for identifying modulator for treatment and prevention of hepatitis; viricides
08/04/2005US20050170336 Using genetic engineering to prepare virus having plurality of recognition sites for selective binding or nucleating; synthesis of trifunctionalized viral particles for use as field effect transistors
08/04/2005US20050169979 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation
08/04/2005US20050169965 Compounds with improved cartilage-inducing and/or bone-inducing activity
08/04/2005US20050169943 Isolating outer membrane preparation, immunogenic component or extract from commensal Neisseria and formulating
08/04/2005US20050169942 Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeutics
08/04/2005US20050169940 Recombinant poxvirus not having a functional 3beta-hsd gene
08/04/2005US20050169939 Produced in cultured cells without Marek's disease contamination
08/04/2005US20050169937 Attacking immune tolerant species; having at least one consensus amino acid sequence
08/04/2005US20050169925 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
08/04/2005US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
08/04/2005US20050169914 Novel functions for decay accelerating factor (DAF) in inflammation
08/04/2005US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase
08/04/2005US20050169911 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
08/04/2005US20050169904 biodrug fusion protein comprising active mitochondrial protein or peptide, a mitochondrial membrane-permeant peptide and linking to a mitochondrial targeting sequence; targeting sequence is cleaved within the mitochondrial matrix, and not cleaved within the cellular cytoplasm; mitochondrial disorders
08/04/2005US20050169899 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals
08/04/2005US20050169892 Adeno-associated virus materials and methods
08/04/2005US20050169891 Tissue tropism of a virus capsid, of protein fragments from different viruses, adenovirus of subgroup C or subgroup B
08/04/2005US20050169890 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase
08/04/2005US20050169888 Methods related to immunostimulatory nucleic acid-induced interferon
08/04/2005US20050169797 A test apparatus is for testing a DNA substrate on which a plurality of DNA fragments for testing are arranged, wherein absolute precision is not required. A substrate is provided on which a plurality of biomolecule spots containing a group of biomolecules
08/04/2005US20050166782 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
08/04/2005CA2595573A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
08/04/2005CA2554472A1 Lawsonia intracellularis subunit vaccines
08/04/2005CA2554214A1 Two-component rna virus-derived plant expression system
08/04/2005CA2554198A1 Process for producing virus vector
08/04/2005CA2553883A1 Anti-cancer antibodies with reduced complement fixation
08/04/2005CA2553828A1 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
08/04/2005CA2553757A1 Gene markers linked to fusarium head blight-resistance factor and utilization thereof
08/04/2005CA2553756A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
08/04/2005CA2553745A1 Mutant sodium channel nav1.7 and methods related thereto
08/04/2005CA2553731A1 Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell
08/04/2005CA2553541A1 Chimpanzee adenovirus vaccine carriers
08/04/2005CA2553503A1 Expression of mammalian proteins in pseudomonas fluorescens
08/04/2005CA2553468A1 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
08/04/2005CA2553265A1 Modulation of line-1 reverse transcriptase
08/04/2005CA2553257A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
08/04/2005CA2552892A1 O-linked glycosylation of peptides
08/04/2005CA2552756A1 Mouse model for psoriasis and psoriatic arthritis
08/04/2005CA2552063A1 Method for producing carotenoids and bacteria used therefor
08/04/2005CA2548484A1 Method for modifying gene expression of a phytopathogenic fungus
08/03/2005EP1560026A1 Methods of detecting collagen degradation
08/03/2005EP1560025A2 Specific markers for diabetes
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559794A2 Multiplex PCR primer set for human HNF-1alpha gene amplification
08/03/2005EP1559793A2 Polynucleotide microarray including two or more groups of probe polynucleotides immobilized on substrate according to melting temperature and method for detecting target polynucleotides using the same
08/03/2005EP1559792A2 Gene-related RNAi transfection method
08/03/2005EP1559791A2 Detection and quantification of siRNA on micro-arrays
08/03/2005EP1559789A2 Method for producing dipeptide
08/03/2005EP1559788A1 Use lipase for improving doughs and baked products
08/03/2005EP1559787A1 Cold-resistant pyruvate phosphate dikinase.
08/03/2005EP1559786A1 Membrane protein originating in mast cells
08/03/2005EP1559785A1 Oligo- or polynucleotides for achieving RNA interference in mammalian cells
08/03/2005EP1559784A2 Rapid extraction of RNA from cells and tissues
08/03/2005EP1559783A1 Method for the chromatographic separation of nucleic acid mixtures
08/03/2005EP1559782A1 Human artificial chromosome (hac) vector
08/03/2005EP1559781A1 Method of detecting bone paget's disease
08/03/2005EP1559779A1 Modified inosine monophosphate dehydrogenases
08/03/2005EP1559778A1 Proliferation of hepatocyte precursors
08/03/2005EP1559776A2 Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system and promoters and terminators for use therein
08/03/2005EP1559726A2 Growth differentiation factor-10
1 ... 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 ... 4023